Adenosine and opioid receptor-mediated cardioprotection in the rat: Evidence for cross-talk between receptors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  Peart, Jason N ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

ATP sensitive potassium channel; Reactive oxygen species

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5 HYDROXYDECANOIC ACID; 7 BENZYLIDENENALTREXONE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; FREE RADICAL; MORPHINE SULFATE; OPIATE AGONIST; OPIATE RECEPTOR; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; TIOPRONIN;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; TREATMENT OUTCOME;

EID: 0038339373     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00985.2002     Document Type: Article

References (67)

1. Armstrong S and Ganote CE. In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C. Cardiovasc Res 29: 647-652, 1995.
2. Asimakis GK, Inners-McBride K, and Conti VR. Attenuation of postischaemic dysfunction by ischaemic preconditioning is not mediated by adenosine in the isolated rat heart. Cardiovasc Res 27: 1522-1530, 1993.
3. Bailey A, Matthes H, Kieffer B, Slowe S, Hourani SM, and Kitchen I. Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the μ-opioid receptor gene. Brain Res 943: 68-79, 2002.
4. Baxter G. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res 55: 483, 2002.
5. Bolling SF, Childs KF, and Ning XH. Adenosine's effect on myocardial functional recovery: substrate or signal? J Surg Res 57: 591-595, 1994.
6. Chieng B and Bekkers JM. Inhibition of calcium channels by opioid- and adenosine-receptor agonists in neurons of the nucleus accumbens. Br J Pharmacol 133: 337-344, 2001.
7. ATP channels. Circ Res 89: 273-278, 2001.
8. Coupar IM and Tran BL. Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine. Life Sci 69: 779-790, 2001.
9. 3 adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol 283: H1562-H1568, 2002.
10. Dana A, Skarli M, Papakrivopoulou J, and Yellon DM. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 86: 989-997, 2000.
11. 3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 363: 81-86, 2001.
12. 1 receptor stimulation during reperfusion following ischaemia. Br J Pharmacol 118: 355-363, 1996.
13. Fryer RM, Hsu AK, Nagase H, and Gross GJ. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther 294: 451-457, 2000.
14. Genade S, Moolman JA, and Lochner A. Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J S Afr 12: 8-16, 2001.
15. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, and Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621, 1995.
16. 1 receptors in ischemic rat hearts. Cardiovasc Res 31: 511-517, 1996.
17. Halimi G, Devaux C, Clot-Faybesse O, Sampol J, Legof L, Rochat H, and Guieu R. Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur J Pharmacol 398: 217-224, 2000.
18. Hayashi E, Mori M, Yamada S, and Kumitomo M. Effects of purine compounds on cholinergic nerves. Specificity of adenosine and related compounds on acetylcholine release in electrically stimulated guinea pig ileum. Eur J Pharmacol 48: 297-307, 1978.
19. 1-adenosine receptors. Am J Physiol Heart Circ Physiol 279: H1690-H1697, 2000.
20. Hedqvist P and Fredholm BB. Effects of adenosine on adrenergic neurotransmission: prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol 293: 217-223, 1976.
21. Hellewell PG and Pearson JD. Metabolism of circulating adenosine by the porcine isolated perfused lung. Circ Res 53: 1-7, 1983.
22. 3 receptors. J Pharmacol Exp Ther 280: 122-128, 1997.
23. ATP channels. Am J Physiol Heart Circ Physiol 280: H377-H383, 2001.
24. 3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100: 2849-2857, 1997.
25. Jones CE, Thomas JX Jr, Devous MD, Norris CP, and Smith EE. Positive inotropic response to inosine in the in situ canine heart. Am J Physiol Heart Circ Physiol 233: H438-H443, 1977.
26. Kaplan GB and Coyle TS. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur J Pharmacol 362: 1-8, 1998.
27. 1 receptors in morphine dependence. Brain Res 657: 347-350, 1994.
28. ATP channel linked mechanisms in rats. Br J Anaesth 84: 204-214, 2000.
29. 1 antagonist DPCPX. Am J Physiol Heart Circ Physiol 281: H847-H853, 2001.
30. Kitchen I, Slowe SJ, Matthes HW, and Kieffer B. Quantitative autoradiographic mapping of μ-, δ- and κ-opioid receptors in knockout mice lacking the μ-opioid receptor gene. Brain Res 778: 73-88, 1997.
31. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD, Downey JM, and Benoit JN. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97: 365-373, 2002.
32. Lasley RD, Anderson GM, and Mentzer RM Jr. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 27: 565-570, 1993.
33. Lee JW, Joshi S, Chan JS, and Wong YH. Differential coupling of μ-, δ- and κ-opioid receptors to G α16-mediated stimulation of phospholipase C. J Neurochem 70: 2203-2211, 1998.
34. ATP channel. Am J Physiol Heart Circ Physiol 271: H1769-H1777, 1996.
35. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15: 298-306, 1994.
36. Liu Y and Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol Heart Circ Physiol 263: H1107-H1112, 1992.
37. ATP channels and PKC-ε. Am J Physiol Heart Circ Physiol 282: H1380-H1386, 2002.
38. Meldrum DR, Cleveland JC Jr, Rowland RT, Banerjee A, Harken AH, and Meng X. Early and delayed preconditioning: differential mechanisms and additive protection. Am J Physiol Heart Circ Physiol 273: H725-H733, 1997.
39. Minatoguchi S, Uno Y, Kariya T, Arai M, Wang N, Hashimoto Y, Maruyama R, Takemura G, Fujiwara T, and Fugiwara H. Cross-talk among noradrenaline, adenosine and protein kinase C in the mechanisms of ischemic preconditioning in rabbits. J Cardiovasc Pharmacol 41: S39-S47, 2003.
40. 2 receptor activation in human heart. J Am Coll Cardiol 29: 1599-1606, 1997.
41. Murthy KS and Makhlouf GM. Opioid μ, δ, and κ receptor-induced activation of phospholipase C-β 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle. Mol Pharmacol 50: 870-877, 1996.
42. Okwuasaba FK, Hamilton JT, and Cook MA. Relaxations of guinea-pig fundic strip by adenosine, adenine nucleotides and electrical stimulation: antagonsism by theophylline and desensitization to adenosine and its derivatives. Eur J Pharmacol 46: 181-198, 1977.
43. ATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol 283: H440-H447, 2002.
44. Parsons M, Young L, Lee JE, Jacobson KA, and Liang BT. Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J 14: 1423-1431, 2000.
45. Patel HH, Hsu AK, Peart JN, and Gross GJ. Sarcolemmal KATP channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res 91: 186-188, 2002.
46. ATP channel opening. FASEB J 16: 1468-1470, 2002.
47. Patel HH, Hsu A, Moore J, and Gross GJ. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol 33: 1455-1465, 2001.
48. Peart J, Flood A, Linden J, Matherne GP, and Headrick JP. Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart. J Cardiovasc Pharmacol 39: 117-129, 2002.
49. Peart J, Matherne GP, Cerniway RJ, and Headrick JP. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart. Cardiovasc Res 52: 120-129, 2001.
50. Peart J, Willems L, and Headrick JP. Receptor and nonreceptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol 284: H519-H527, 2003.
51. Sandner-Kiesling A, Li X, and Eisenach JC. Morphine-induced spinal release of adenosine is reduced in neuropathic rats. Anesthesiology 95: 1455-1459, 2001.
52. Sato T, Obata T, Yamanaka Y, and Arita M. The effect of glibenclamide on the production of interstitial adenosine by inhibiting ecto-5′-nucleotidase in rat hearts. Br J Pharmacol 122: 611-618, 1997.
53. Sawynok J and Jhamandas KH. Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J Pharmacol Exp Ther 197: 379-390, 1976.
54. Schultz JJ, Hsu AK, and Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the δ-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29: 2187-2195, 1997.
55. 1- but not μ- or κ-opioid receptors. Circulation 97: 1282-1289, 1998.
56. 3 adenosine receptor activation in reduction of cardiomyocyte injury caused by hypoxic stress and in induction of apoptosis in rat cardiomyocyte cultures. Adv Exp Med Biol 486: 201-205, 2000.
57. Sinclair CJ, Shepel PN, Geiger JD, and Parkinson FE. Stimulation of nucleoside efflux and inhibition of adenosine kinase by A1 adenosine receptor activation. Biochem Pharmacol 59: 477-483, 2000.
58. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88: 520-528, 2001.
59. Takeishi Y, Jalili T, Ball NA, and Walsh RA. Responses of cardiac protein kinase C isoforms to distinct pathological stimuli are differentially regulated. Circ Res 85: 264-271, 1999.
60. 3 receptors on mast cells. J Clin Invest 105: 361-367, 2000.
61. Tosaki A, Maulik N, Cordis G, Trifan OC, Popescu LM, and Das DK. Ischemic preconditioning triggers phospholipase D signaling in rat heart. Am J Physiol Heart Circ Physiol 273: H1860-H1866, 1997.
62. ATP channels in adenosine-enhanced ischemic preconditioning. Am J Physiol Heart Circ Physiol 279: H2694-H2703, 2000.
63. ATP channel activation. Cardiovasc Res 40: 138-145, 1998.
64. 2+ overload injury in rat myocardium. Circ Res 84: 1156-1165, 1999.
65. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 280: H246-H255, 2001.
66. Yellon DM, Baxter GF, Garcia-Dorado D, Heusch G, and Sumeray MS. Ischaemic preconditioning: present position and future directions. Cardiovasc Res 37: 21-33, 1998.
67. ATP channel. J Mol Cell Cardiol 34: 263-277, 2002.